| Model Number |
H787CT96STSD0 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Bacterial Infection (1735)
|
| Date of Event |
02/01/2020
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The device is not available to be returned to the manufacturer for evaluation.An investigation into the root cause for the event is currently in progress.The results of the investigation will be sent via a follow up medwatch.Reference: (b)(4).
|
| |
|
Event or Problem Description
|
|
On or about (b)(6) 2019, plaintiff underwent placement of the angiodynamics smartport power injectable port, lot number 5430649 reference number h787ct96stsd0.The device was implanted by (b)(6), md, at (b)(6) medical center in (b)(6), for breast cancer treatment.On or about (b)(6) 2020, plaintiff presented to (b)(6) medical center in (b)(6), where his implanted port was removed due to infection.The plaintiff was diagnosed with bacteremia.
|
| |
|
Additional Manufacturer Narrative
|
|
The customer's reported complaint description of patient infection cannot be confirmed given the patient centric nature of this serious adverse event (sae).No port device was returned for evaluation since there was no report of port device malfunction, damage or performance issue during in situ use/treatment.A device history record (dhr) review of the indicated packaging lot revealed no quality related issues or manufacturing deficiencies at the time of manufacture.Sterilization load release records were reviewed for the packaging lot in question; no issues were observed.There have been no other reported complaints for the indicated packaging lot for similar patient infection issue.The port was implanted into the patient more than 9 months prior to the patient's infection.There was no report of port device malfunction or performance issue during the implant procedure/use.If the manufacturing/packaging/sterilization of the port device in question was to contribute to an infection in the patient it would have likely occurred shortly after the implant date and not more than 9 months later.Device directions for use (dfu) cautions that each access of the port should be performed using aseptic technique, following the institutions universal precautions.There is no indication from the reported complaint that the manufacturing/packaging/sterilization of the port device could have contributed to the patient's infection.Infection is cautioned in the device dfu as a potential complication of port system use.
|
| |
|
Search Alerts/Recalls
|